← Evidence map

ReviewDrugs2022

BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy.

Barry Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35412114